SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pathogenesis(pgns)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: fossilmark who wrote (64)3/29/1998 1:00:00 PM
From: Huck  Read Replies (1) of 228
 
I think they probably sold a ton of it. There is a lot of interest in the CF world over this drug and the results of the test were presented at several CF conferences during the past year (where a lot of clinicians gathered). They also had a sales force ready and waiting since last Fall. Also, the inventory channel in the pharmacies and CF centers had to be filled regardless of demand. But I think demand will be high, my gosh, there hasn't been a new drug for CF in about twenty years! Anyway, just my opinion.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News